Meet
Features
Solutions
Pricing
Sales Intelligence
Qualify prospects and connect with decision makers effortlessly
Research Companies & Directors
Make important decisions with absolute confidence
Create B2B Marketing Lists
Target and reach more of your ideal prospects than ever
Monitor Risks & Opportunities
Be the first to learn about changes in the companies that matter
Cleanse Your B2B Database
Instantly transform old records into new opportunities
Perform KYC Checks
Completely understand who you're working with
Discover New Businesses
Identify and connect with new companies as soon as they register
Company Credit Reports
See how companies are performing year–on–year and explore their debts
UPGRADE
Contact
Credit Report
Financials
People
Ownership
Latest Activity
Mutual Companies
Documents
Repayment History
Ottimo Pharma Limited
Ottimo Pharma Limited is an active company incorporated on 3 March 2017 with the registered office located in Sandwich, Kent. Ottimo Pharma Limited was registered 8 years ago.
Watch Company
Status
Active
Active since
incorporation
Company No
10650475
Private limited company
Age
8 years
Incorporated
3 March 2017
Size
Micro
Turnover is under
£1M
Under
10 employees
Confirmation
Submitted
Dated
21 January 2025
(9 months ago)
Next confirmation dated
21 January 2026
Due by
4 February 2026
(2 months remaining)
Last change occurred
8 months ago
Accounts
Submitted
For period
1 Jan
⟶
31 Dec 2024
(1 year)
Accounts type is
Small
Next accounts for period
31 December 2025
Due by
30 September 2026
(10 months remaining)
Learn more about Ottimo Pharma Limited
Contact
Update Details
Address
C/O Kreston Reeves Llp Innovation House
Ramsgate Road
Sandwich
Kent
CT13 9FF
United Kingdom
Same address for the past
8 years
Companies in CT13 9FF
Telephone
Unreported
Email
Unreported
Website
Unreported
See All Contacts
People
Officers
9
Shareholders
21
Controllers (PSC)
1
David Epstein
Director • American • Lives in United States • Born in Jul 1961
Srinivas Akkaraju
Director • American • Lives in United States • Born in Mar 1968
Dr James Edward Coleman
Director • British • Lives in Scotland • Born in Jul 1975
James Sabry
Director • American • Lives in United States • Born in Dec 1958
Peter Armstrong Thompson
Director • American • Lives in United States • Born in Jul 1959
See Key People
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
See All Shareholders, PSCs & Group Structure
Mutual Companies
Levicept Ltd
Francesco De Rubertis is a mutual person.
Active
Kaerus Bioscience Limited
Francesco De Rubertis is a mutual person.
Active
Vicebio Limited
Mark David Chin is a mutual person.
Active
Ultrahuman One Limited
Dr James Edward Coleman, Dr William James Jonathan Finlay, and 1 more are mutual people.
Dissolved
Ultrahuman Thirteen Limited
Dr James Edward Coleman, Dr William James Jonathan Finlay, and 1 more are mutual people.
Liquidation
Ultrahuman Fourteen Limited
Dr James Edward Coleman, Dr William James Jonathan Finlay, and 1 more are mutual people.
Dissolved
Ultrahuman Ten Limited
Dr James Edward Coleman, Dr William James Jonathan Finlay, and 1 more are mutual people.
Dissolved
Ultrahuman Nine Limited
Dr James Edward Coleman, Dr William James Jonathan Finlay, and 1 more are mutual people.
Dissolved
See All Mutual Companies
Financials
Net Assets, Total Assets & Total Liabilities (2017–2024)
Period Ended
31 Dec 2024
For period
31 Dec
⟶
31 Dec 2024
Traded for
12 months
Cash in Bank
£112.9M
Increased by £111.91M (+11364%)
Turnover
Unreported
Same as previous period
Employees
4
Same as previous period
Total Assets
£113.65M
Increased by £112.49M (+9693%)
Total Liabilities
-£1.4M
Increased by £1.22M (+674%)
Net Assets
£112.25M
Increased by £111.27M (+11354%)
Debt Ratio (%)
1%
Decreased by 14.32% (-92%)
See 10 Year Full Financials
Latest Activity
Group Accounts Submitted
6 Months Ago on 13 May 2025
Mr Roger Delemere Dansey Appointed
8 Months Ago on 17 Mar 2025
Confirmation Submitted
8 Months Ago on 4 Mar 2025
William James Jonathan Finlay Resigned
10 Months Ago on 18 Dec 2024
Srinivas Akkaraju Appointed
10 Months Ago on 18 Dec 2024
Mr Peter Armstrong Thompson Appointed
10 Months Ago on 18 Dec 2024
Mr Mark David Chin Appointed
10 Months Ago on 18 Dec 2024
Mr James Sabry Appointed
1 Year Ago on 15 Oct 2024
Mr David Epstein Appointed
1 Year 1 Month Ago on 7 Oct 2024
James Edward Coleman Resigned
1 Year 1 Month Ago on 28 Sep 2024
Get Alerts
Get Credit Report
Discover Ottimo Pharma Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
See All Credit Score & Limits
Documents
Resolutions
Submitted on 16 Jun 2025
Amended accounts for a small company made up to 31 December 2024
Submitted on 16 May 2025
Group of companies' accounts made up to 31 December 2024
Submitted on 13 May 2025
Statement of capital following an allotment of shares on 20 February 2025
Submitted on 6 May 2025
Appointment of Mr Roger Delemere Dansey as a director on 17 March 2025
Submitted on 24 Apr 2025
Resolutions
Submitted on 25 Mar 2025
Confirmation statement made on 21 January 2025 with updates
Submitted on 4 Mar 2025
Termination of appointment of William James Jonathan Finlay as a director on 18 December 2024
Submitted on 26 Feb 2025
Appointment of Srinivas Akkaraju as a director on 18 December 2024
Submitted on 26 Feb 2025
Appointment of Mr Peter Armstrong Thompson as a director on 18 December 2024
Submitted on 24 Feb 2025
Explore All Documents
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
See All Charges & CCJs